Cue Biopharma Inc CUE

$27.66 +5.33 (23.87%)

Valuation

Market cap
200,933,000
Revenue TTM
$27,470,000
Net income TTM
$-26,600,000
PE ratio
0.00
Forward PE
—
Profit margin
-96.83%
Debt to equity
0.00

Trading

Volume
394,600
Avg volume
298,938
Day's range
$22.10 – $29.00
Shares out
7,264,000
Stochastic %K
82%
Beta
2.62
Analysts
Strong Sell
Price target
$81.02

Price

Company profile

Cue Biopharma, Inc., a clinical-stage therapeutics company, focuses on developing various therapies for immunological disorders. The company's lead asset is CUE-221, an anti-IgE antibody with a dual-mechanism of action currently in Phase 2 development for allergic diseases. It also developed the Immuno-STAT platform, which targets disease-specific T cells in vivo without broad immune modulation. The company's lead au...

Show more

Cue Biopharma, Inc., a clinical-stage therapeutics company, focuses on developing various therapies for immunological disorders. The company's lead asset is CUE-221, an anti-IgE antibody with a dual-mechanism of action currently in Phase 2 development for allergic diseases. It also developed the Immuno-STAT platform, which targets disease-specific T cells in vivo without broad immune modulation. The company's lead autoimmune candidate is CUE-401, a bifunctional IL-2 and TGF-B program that is advancing towards Phase 1 development to regulate inflammation and drive Treg-mediated tolerance. The company was formerly known as Imagen Biopharma, Inc. and changed its name to Cue Biopharma, Inc. in October 2016. Cue Biopharma, Inc. was incorporated in 2014 and is headquartered in Boston, Massachusetts.

Industry
Biotechnology
Sector
Healthcare
Phone
617 949 2680
Website
https://www.cuebiopharma.com
Address
40 Guest Street, Boston, United States

Latest news

Stocktwits

TradeWiseSignals Oct 10, 5:23 PM
$CUE guys how do I get to know about these pennies before they rip? Any groups or anything that I can join?
0 replies
CantNameThatTune Oct 9, 10:50 PM
$CUE Congrats on today and to those who knew this was coming. But pay attention now ladies. Tales of a Yo-Yo $31 a couple weeks ago. DOWN to $23's UP to $27's DOWN to $21's UP to $29 today Therefore?
1 replies
daprinta Oct 9, 8:38 PM
$CUE let the party resume…now take the leg braces off & watch Forrest Gump run…as far & as fast as Forrest can run is wat Cue-ball will be doing…now image if Gumps hair was on fire 🔥…how much faster u think he cud run if he had to…that’s Cue’s white hot data that’s on its way which will make this stock F’n fly…1st resistance test @ $38 & then…virtually unlimited until a proper partnership announcement is made with a tier one by a Pharma or a suitor offers them a deal that they can’t resist… grab your popcorn!
0 replies
topstockalerts Oct 9, 7:50 PM
Todays Top Gainers PT2 $AGRZ $QSI $CUE $OFAL $SMJF
0 replies
topstockalerts Oct 9, 7:09 PM
Top Gainers PT2 $SMJF $NAUT $CUE $PDSB $VRXA
0 replies
topstockalerts Oct 9, 6:34 PM
Top Gainers PT2 $SMJF $NAUT $CUE $PDSB $VRXA
0 replies
Hereinbama35 Oct 9, 6:09 PM
$CUE why?
1 replies
topstockalerts Oct 9, 5:51 PM
Top Gainers PT2 $MI $CUE $SMJF $PDSB $FEAM
1 replies